Machine Learning-Based Brightfield Detection of Anti-Fibrotic Effects in a 3D Retinal Fibrosis Model.

Authors

Thomas Hofstetter, Özlem Yavas Grining, Christophe Roubeix, Peter D Westenskow, David A Fluri

Published in

SLAS discovery : advancing life sciences R & D. Pages 100343. Oct 11, 2026. Epub Oct 11, 2026.

Abstract

Three-dimensional (3D) spheroid and microtissue models are increasingly used in phenotypic drug discovery, yet their scalability for high-throughput screening often remains limited, constrained by the cost and complexity of conventional imaging-based readouts. Here, we present a morphology-based screening approach using low-resolution brightfield images of human retinal pigment epithelium microtissues (hRPE-MTs) to identify fibrotic and non-fibrotic phenotypes. The results of this study demonstrate that extracting geometric, intensity, and texture features from segmented spheroids enables quantitative characterization of fibrosis-associated morphological changes. Machine learning classifiers trained on these features effectively discriminated between fibrotic and non-fibrotic hRPE-MTs. Collectively, these findings indicate that label-free brightfield morphology encodes sufficient information to support scalable phenotypic screening in 3D fibrosis models. This approach provides a low-complexity and broadly accessible strategy for early-stage drug discovery.

PMID:
42860212
Bibliographic data and abstract were imported from PubMed on 12 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.